Chiesi Usa, Inc.Usage: Kengreal is used during percutaneous coronary intervention (PCI) to reduce the risk of heart attack, repeat revascularization, and stent thrombosis in patients not previously treated with a P2Y12 inhibitor or glycoprotein IIb/IIIa inhibitor.